Lung function and health-related quality of life among adult patients following pulmonary TB treatment.


Journal

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
ISSN: 1815-7920
Titre abrégé: Int J Tuberc Lung Dis
Pays: France
ID NLM: 9706389

Informations de publication

Date de publication:
01 Sep 2024
Historique:
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: ppublish

Résumé

<sec><title>OBJECTIVES</title>Pulmonary TB (PTB) increases the risk of chronic lung complications, which are associated with increased morbidity and mortality. We determined the prevalence and predictors of post-TB lung disease and persistent symptoms in a resource-limited setting.</sec><sec><title>METHODS</title>Adults who completed PTB treatment underwent spirometry and completed the St. George's Respiratory Questionnaire (SGRQ), a questionnaire that assesses quality of life on symptom, activity, and impact. We performed multivariate analyses to calculate the X-adjusted prevalence ratio (PR

Identifiants

pubmed: 39187999
doi: 10.5588/ijtld.24.0029
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

419-426

Auteurs

J Zawedde (J)

Makerere University School of Public Health, Kampala, Infectious Diseases Research Collaboration, Kampala, Uganda.

R Abelman (R)

Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA.

E Musisi (E)

Infectious Diseases Research Collaboration, Kampala, Uganda.

A Nyabigambo (A)

Makerere University School of Public Health, Kampala.

I Sanyu (I)

Infectious Diseases Research Collaboration, Kampala, Uganda.

S Kaswabuli (S)

Infectious Diseases Research Collaboration, Kampala, Uganda.

P Byanyima (P)

Infectious Diseases Research Collaboration, Kampala, Uganda.

E Lewis (E)

Department of Anesthesia, San Francisco General Hospital, San Francisco, CA, USA.

A Sessolo (A)

Infectious Diseases Research Collaboration, Kampala, Uganda.

R Lalitha (R)

Makerere University College of Health Sciences; Kampala, Uganda.

N Kiwanuka (N)

Makerere University School of Public Health, Kampala.

K Crothers (K)

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA.

W Worodria (W)

Infectious Diseases Research Collaboration, Kampala, Uganda.

J L Davis (JL)

Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT.

L Huang (L)

Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, CA, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH